119 Thorough QTc (TQT) interval assessment of a novel nonimmediate release oral tranexamic acid product on ventricular repolarization in fasting healthy women

Sunday, April 26, 2009
Keith A. Moore, PharmD , Xanodyne Pharmaceuticals, Inc, Newport, KY
Timothy S. Callahan, PhD , Biomedical Systems, Inc, St. Louis, MO
Pierre Maison-Blanche, MD , Biomedical Systems, Inc, St. Louis, MO
Isabelle Morin, BSc , MDS Pharma Services, Montreal, QC, Canada
Ted Marenco, MSc , MDS Pharma Services, Montreal, QC, Canada
<< Previous Abstract | Next Abstract